4.7 Article

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

Journal

ANNALS OF INTERNAL MEDICINE
Volume 162, Issue 11, Pages 777-784

Publisher

AMER COLL PHYSICIANS
DOI: 10.7326/M14-2385

Keywords

-

Funding

  1. Canadian Agency for Drugs and Technologies in Health
  2. Pfizer Canada
  3. Canadian Institutes of Health Research
  4. Drug Safety and Effectiveness Network
  5. Medical Research Council Population Health Science Fellowship [G0902118]
  6. Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research [CGV 121171]
  7. Canadian Institutes of Health Research Drug Safety and Effectiveness Network team grant [116573]
  8. Laura and John Arnold Foundation
  9. Cancer Research UK [16895] Funding Source: researchfish
  10. Medical Research Council [G0902118, MR/K023233/1] Funding Source: researchfish
  11. MRC [G0902118, MR/K023233/1] Funding Source: UKRI

Ask authors/readers for more resources

The PRISMA statement is a reporting guideline designed to improve the completeness of reporting of systematic reviews and meta-analyses. Authors have used this guideline worldwide to prepare their reviews for publication. In the past, these reports typically compared 2 treatment alternatives: With the evolution of systematic reviews that compare multiple treatments, some of them only indirectly, authors face novel challenges for conducting and reporting their reviews. This extension of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) statement was developed specifically to improve the reporting of systematic reviews incorporating network meta-analyses. A group of experts participated in a systematic review, Delphi survey, and face-to-face discussion and consensus meeting to establish new checklist items for this extension statement. Cur-rent PRISMA items were also clarified. A modified, 32-item PRISMA extension checklist was developed to address what the group considered to be immediately relevant to the reporting of network meta-analyses. This document presents the extension and provides examples of good reporting, as well as elaborations regarding the rationale for new checklist items and the modification of previously existing items from the PRISMA statement. It also highlights educational information related to key considerations in the practice of network meta-analysis. The target audience includes authors and readers of network meta-analyses, as well as journal editors and peer reviewers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available